Experimental models of liver fibrosis.

Crespo Yanguas, Sara;Cogliati, Bruno;Willebrords, Joost;Maes, Michaël;Vinken, Mathieu;et.al.
(2016) Archives of Toxicology — Vol. 90, n° 5, p. 1025-1048 (2016)

Files

98ArchivesofToxicology.pdf
  • Closed Access
  • Adobe PDF
  • 1.97 MB

Details

Authors
  • Crespo Yanguas, Sara
    Author
  • Cogliati, Bruno
    Author
  • Willebrords, Joost
    Author
  • Maes, Michaël
    Author
  • Author
  • Vinken, Mathieu
    Author
Show more
Abstract
Hepatic fibrosis is a wound healing response to insults and as such affects the entire world population. In industrialized countries, the main causes of liver fibrosis include alcohol abuse, chronic hepatitis virus infection and non-alcoholic steatohepatitis. A central event in liver fibrosis is the activation of hepatic stellate cells, which is triggered by a plethora of signaling pathways. Liver fibrosis can progress into more severe stages, known as cirrhosis, when liver acini are substituted by nodules, and further to hepatocellular carcinoma. Considerable efforts are currently devoted to liver fibrosis research, not only with the goal of further elucidating the molecular mechanisms that drive this disease, but equally in view of establishing effective diagnostic and therapeutic strategies. The present paper provides a state-of-the-art overview of in vivo and in vitro models used in the field of experimental liver fibrosis research.
Affiliations

Citations

Crespo Yanguas, S., Cogliati, B., Willebrords, J., Maes, M., Colle, I., van den Bossche, B., de Oliveira, C. P. M. S., Andraus, W., Alves, V. A., Leclercq, I., & Vinken, M. (2016). Experimental models of liver fibrosis. Archives of Toxicology, 90(5), 1025-1048. https://doi.org/10.1007/s00204-015-1543-4 (Original work published 2016)